FOOT AND MOUTH DISEASE VACCINE MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America remains the dominant region in the global foot and mouth disease vaccine market with estimated market share of 38.2 % in 2024. The U.S. accounts for the majority of the market share due to strong presence of leading vaccine manufacturers in the country. Strong support from the government agencies for livestock healthcare and favorable regulations have boosted vaccine adoption among farmers. Furthermore, the high-quality certifications for vaccines by regulatory bodies ensures consumer safety and confidence.  The North American Free Trade Agreement has also enhanced exports of American vaccines to Mexico and Canada over the years.

Asia Pacific has emerged as the fastest growing regional market for foot and mouth disease vaccine globally. Rapid expansion of the dairy and meat industries together with rising livestock counts in major countries like India and China are driving increased prevention through vaccination. To protect their massive cattle population and meet the burgeoning demand for milk and meat, the APAC governments are focused on extensive vaccination programs. This has lured multinational corporations to establish production facilities and collaborate with local players. Counties like India often have price control mechanisms in place to ensure affordability of vaccines for small farmers. This has made vaccines highly accessible and supported strong revenue growth of regional and global participants.